XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 27.25

+4.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9337)	3/23/1999 10:47:00 AM
From: dlc	Read Replies (1) of 17367

George, you are correct that I didn't have the "facts". That is why I asked you to contact Xoma. If you can confirm that the data will be officially released so many days after the end of the trial that would be very useful to know. The fact that MAGN had an entirely new kind of drug that showed efficacy against bacteria and this was not enough to make the FDA happy makes me very nervous. The FDA approval hurdle seems to be getting too high for many new drugs. The mortality data for Neuprex better look awfully good. The key is knowing when this data will be released to the public. Can anyone find this out?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next